Tying price to value — from drugs to hip surgery — still elusive

BOSTON — As the cost of health care rises, academic and industry leaders batted around ideas to make medicine more affordable by having people pay for the benefit they accrue rather than the specific services they receive.

Called “value-based care,” the concept is complicated and amorphous — but it touches all areas of health care, from hospital procedures to medical research to pharmaceutical pricing.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.